tradingview.comAUG 211 min read

Latham Group Secures $375 Million Credit Facilities Led by Jefferies Finance; Replaces 2022 Loan

Latham Group (SWIM) secured $375 million in new credit facilities, including a $75 million revolving credit line and a $300 million term loan, led by Jefferies Finance. The facilities will refinance and extend the company's maturities, replacing a 2022 Barclays-led agreement. The revolver matures in 2031, and the term loan in 2033.

Original reporting

tradingview.com

Published Aug 21, 2026, 12:53 PM UTC

Analysis

AlphAI AI DeskAI-generated

Added to AlphAI Aug 21, 2026, 9:14 PM UTC. Informational, not investment advice.

How this was made

AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.

About AlphAI AI Desk Scoring methodology Report an issue

Latham Group Secures $375 Million Credit Facilities Led by Jefferies Finance; Replaces 2022 Loan — source image — Source · tradingview.com

Decision brief

The 30-second read

Med

Why it matters

The $375 M credit package strengthens liquidity and extends debt maturities, likely viewed positively by investors.

Market read

Primary corporate financing news with material dollar amount; relevant for debt‑focused traders.

What to watch

Potential covenants and mandatory prepayment terms could constrain future cash flow.

Relevance 7/10Novelty 8/10Timing: effective Aug 20 2026

Background

Latham Group is refinancing its 2022 Barclays‑led credit facility.

Market effects

Sector

May signal increased credit availability for mid‑cap industrial firms.

Regional

Limited to U.S. markets where Latham Group trades.

Global

Low

Counterpoint

What could challenge this read

If the facility terms are tighter than expected, the stock could face pressure.

Key entities

Lender
Jefferies Finance
Administrative agent for the new credit facility.
Former Lender
Barclays Bank
Provider of the terminated 2022 credit agreement.

Read at source ← All news

SEP 1

HighAI 9/10

Latham Leads Epiris' £1B Buy Of Gamma Communications

Epiris LLP will acquire Gamma Communications PLC for £1.015 billion ($1.374 billion), taking the U.K. telecommunications company private, according to the firms. The deal was announced Tuesday.

law360.com1 min

AUG 22

Med

Latham Group Refinances Capital Structure with New Credit Facilities

Latham Group (SWIM) refinanced its capital structure with new credit facilities totaling $375 million. The facilities include a $75 million revolving credit line and a $300 million term loan, both secured by company assets. Proceeds were used to repay existing debt. The facilities mature in 2031 and 2033, respectively, and include leverage-based interest margins and covenants.

theglobeandmail.com1 min

AUG 18

$FULCMedAI 8/10

Latham Advises Frazier Life Sciences on Private Placement Financing in Connection With Fulcrum Therapeutics and Slate Medicines Merger

Fulcrum Therapeutics (Nasdaq: FULC) and Slate Medicines announced a definitive all-stock merger. The combined company will operate as Slate Medicines, Inc. and is expected to trade on Nasdaq as SLTE. Slate secured commitments for an oversubscribed concurrent private placement of $245 million led by Frazier Life Sciences, with other healthcare investors participating.

lw.com2 min

AUG 12

$SWIMMedAI 8/10

Latham Group (SWIM) Q2 2026 Earnings Call Transcript

Latham Group, Inc. (SWIM) reported Q2 2026 net sales of $197.5 million, up 14.4% year over year, driven by 10.3% organic growth and the Freedom Pools acquisition. Adjusted EBITDA rose to $44.6 million. Net income fell to $12.8 million due to a $5.0 million FX impact. Full-year guidance: net sales $600 million to $620 million, adjusted EBITDA $110 million to $120 million.

fool.com7 min

AUG 5

$LOGCMedAI 8/10

Latham Represents Blackstone Credit & Insurance in Financing for ContextLogic’s Acquisition of gChem for US$850 Million

ContextLogic Holdings (OTCQB: LOGC) said it will acquire gChem, the holding company of Gaylord Chemical and subsidiaries, from funds managed by EagleTree Capital and co-investors. The deal values gChem at an enterprise value of US$850 million. Financing will come from Blackstone Credit & Insurance, including a US$250 million term loan and US$25 million revolver, per the company.